NO20083854L - Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel - Google Patents

Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel

Info

Publication number
NO20083854L
NO20083854L NO20083854A NO20083854A NO20083854L NO 20083854 L NO20083854 L NO 20083854L NO 20083854 A NO20083854 A NO 20083854A NO 20083854 A NO20083854 A NO 20083854A NO 20083854 L NO20083854 L NO 20083854L
Authority
NO
Norway
Prior art keywords
entinylestradiol
drospirenone
contraceptive
pharmaceutical material
pharmaceutical
Prior art date
Application number
NO20083854A
Other languages
English (en)
Other versions
NO327588B1 (no
NO327588B3 (no
Inventor
Wolfgang Heil
Ralph Lipp
Renate Heithecker
Juergen Hilmann
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20083854(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/IB2000/001213 external-priority patent/WO2001015701A1/en
Publication of NO20083854L publication Critical patent/NO20083854L/no
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO327588B1 publication Critical patent/NO327588B1/no
Publication of NO327588B3 publication Critical patent/NO327588B3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20083854A 1999-08-31 2008-09-08 Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel NO327588B3 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
EP99202826 1999-08-31
PCT/IB2000/001213 WO2001015701A1 (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Publications (3)

Publication Number Publication Date
NO20083854L true NO20083854L (no) 2002-04-26
NO327588B1 NO327588B1 (no) 2009-08-31
NO327588B3 NO327588B3 (no) 2011-05-16

Family

ID=26153358

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20083854A NO327588B3 (no) 1999-08-31 2008-09-08 Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
NO20091809A NO20091809L (no) 1999-08-31 2009-05-07 Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
NO2010004C NO2010004I1 (no) 1999-08-31 2010-02-26 0,02 mg etinylostradiol (som betadexclathrat) og 3mg drospirenon

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20091809A NO20091809L (no) 1999-08-31 2009-05-07 Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
NO2010004C NO2010004I1 (no) 1999-08-31 2010-02-26 0,02 mg etinylostradiol (som betadexclathrat) og 3mg drospirenon

Country Status (11)

Country Link
CN (1) CN1223350C (no)
BG (2) BG109749A (no)
CA (1) CA2382426C (no)
EE (1) EE05317B1 (no)
HR (1) HRP20020258B1 (no)
IL (2) IL197396A (no)
MX (1) MXPA02002043A (no)
NO (3) NO327588B3 (no)
RU (4) RU2269342C9 (no)
SK (1) SK287634B6 (no)
UA (1) UA81387C2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN108606963B (zh) * 2017-12-27 2021-05-18 上海长海医院 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
CN111529482A (zh) * 2020-05-20 2020-08-14 祝培 十一酸睾酮缓释植入剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
WO1998004269A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen

Also Published As

Publication number Publication date
IL200482A0 (en) 2011-07-31
NO2010004I1 (no) 2010-03-22
MXPA02002043A (es) 2003-08-20
NO327588B1 (no) 2009-08-31
EE05317B1 (et) 2010-08-16
RU2010114825A (ru) 2011-10-20
EE200900049A (et) 2009-10-15
SK2572002A3 (en) 2002-11-06
BG106533A (bg) 2002-10-31
RU2449796C9 (ru) 2007-10-27
RU2269342C9 (ru) 2007-10-27
BG65204B1 (bg) 2007-07-31
RU2269342C2 (ru) 2006-02-10
IL197396A (en) 2010-04-29
NO20091809L (no) 2002-04-26
UA81387C2 (en) 2008-01-10
RU2482853C2 (ru) 2013-05-27
NO327588B3 (no) 2011-05-16
BG109749A (bg) 2008-06-30
CA2382426C (en) 2006-02-28
CN1407895A (zh) 2003-04-02
HRP20020258A2 (en) 2005-02-28
RU2005131868A (ru) 2007-04-20
SK287634B6 (sk) 2011-04-05
RU2449796C2 (ru) 2006-02-10
HRP20020258B1 (en) 2007-05-31
CA2382426A1 (en) 2001-03-08
RU2396082C2 (ru) 2010-08-10
CN1223350C (zh) 2005-10-19

Similar Documents

Publication Publication Date Title
NO20083854L (no) Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
CY2009015I2 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
NZ513924A (en) Composition comprising a tramadol material and a selective cox-2 inhibitor drug
ATE284223T1 (de) Zusammensetzung enthaltend ein tramadol und ein antikonvulsives arzneimittel
EE04901B1 (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
HUP0200155A3 (en) Thioamide derivatives, pharmaceutical compositions containing them and their use
NO20014013D0 (no) 16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
HUP0201858A3 (en) Thiazole and oxazole derivatives and their pharmaceutical use
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
NO20000932D0 (no) Farmasøytisk preparat for kombinasjon av piperidinoalkanol og dekongestant
DE69915144D1 (de) Aerosoldruckdosiergeräte und Aerosolarzneizusammensetzungen
PT102291B (pt) Metanossulfonato de paroxetina processos para a sua preparacao composicao farmaceutica contendo o mesmo e sua utilizacao
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
DK1237559T3 (da) Farmaceutiske kombinationer som omfatter en P2T-receptor-antagonist og melagatran
NO20021094L (no) Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer
NO20034778L (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
IS6723A (is) 10-arýl-11H-bensó[b]flúorenafleiður og hliðstæðurtil lyfjanotkunar
PT1202996E (pt) Compostos de titanio a sua preparacao e a sua utilizacao
HUP0104549A3 (en) Imidazo-pyridine sulfonamide derivatives and pharmaceutical compositions thereof
ID28451A (id) Trisiklik piperidin-δ3 sebagai bahan farmasi
HUP0201478A3 (en) Neuroprotective and retinoprotective ophthalmologic medicines
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO20020777L (no) Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: YAZ 0,02 MG/3 MG TABLETTER, FILMDRASJERTE; NAT. REG. NO/DATE: 07-5386 20090422; FIRST REG. NO/DATE: NL , RGV33842 20070629

Spc suppl protection certif: 2010004

Filing date: 20100226

LC4 Limitation of patent rights - b3 (par. 39b patent act)

Effective date: 20110516

CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

REER Request for administrative reevaluation of patent

Opponent name: GEDEON RICHTER PLC, HU

BDEC Board of appeal decision

Free format text: KLAGESAKEN HEVES

Filing date: 20150320

Effective date: 20190628

MK1K Patent expired